Pharmacokinetics of macrolides in foals.
Macrolides are used for treatment of pneumonia and extrapulmonary conditions caused by Rhodococcus equi. In foals, macrolides have an extraordinary capacity to accumulate in different lung tissue compartments. These drugs show unique pharmacokinetic features such as rapid and extensive distribution and long persistence in pulmonary epithelial lining fluid (PELF) and bronchoalveolar lavage (BAL) cells from foals. This article reviews the pharmacokinetic characteristics of erythromycin, azithromycin, clarithromycin, tulathromycin, telithromycin, gamithromycin, and tilmicosin in foals, with emphasis on PELF and BAL cell concentrations.
Department of Microbiology, University of Tennessee, Knoxville, TN, USA.
N
N
Villarino
T
T
Martín-Jiménez
D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood / Q000493:pharmacokinetics*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D006734:Horse Diseases / Q000188:drug therapy; D006736:Horses / Q000378:metabolism; D007408:Intestinal Absorption; D018942:Macrolides / Q000097:blood / Q000493:pharmacokinetics*
D000900:Anti-Bacterial Agents; D018942:Macrolides